and that removal of prostate tissue by TURP (transurethral resection of the prostate) in the treatment of benign prostatic hyperplasia (BPH) reduces the risk of prostate cancer {Cancer. 20,3; 98,1727-34 "Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden").
and that removal of prostate tissue by TURP (transurethral resection of the prostate) in the treatment of benign prostatic hyperplasia (BPH) reduces the risk of prostate cancer {Cancer. 20,3; 98,1727-34 "Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden").
A cohort of 1,9 patients from a part of the Brazilian northeast, submitted to radical prostatectomy or transurethral resection of the prostate. was selected and submitted to immunohistochemical evaluation for ERG and PTEN, with results associated with clinical-pathological characteristics.
Um coorte de 1,9 pacientes de uma parte do nordeste brasileiro, submetidos a prostatectomia radical ou ressecção transuretral da próstata, foi selecionada e submetida a avaliação imuno-histoquímica para pesquisa de ERG e PTEN, com resultados associados às características clínico-patológicas.
transurethral resection of the prostate (TRP) is the surgery technique most frequently used for the treatment of BPH. Anaesthesia for this procedure has its own features becoming a challenge for the anaesthesiologist to manage with its peculiarities.
A Ressecção Transuretral (RTU) de próstata constitui-se na técnica operatória mais empregada atualmente para o tratamento da HPB. A anestesia para este procedimento possui características próprias, tornando-se um desafio para o anestesiologista o manejo de suas particularidades.